PRPO (PRPO) Stock Price & Analysis
PRPO (PRPO) rose 0.00% to USD 23.68 as of July 25, 2026 at 03:09 UTC, according to Nexqual real-time market data.
PRPO last closed at USD 23.68; the session ranged USD 22.5–23.92 on volume of 38,332 shares. Market capitalization is —, with a 52-week range of USD 13.8–33.63 (NCM). Source: Nexqual, July 25, 2026 at 03:09 UTC.
Key Statistics (as of July 25, 2026 at 03:09 UTC)
| Price | USD 23.68 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 23.68 |
| Open | USD 23.68 |
| Day Range | USD 22.5 – 23.92 |
| 52-Week Range | USD 13.8 – 33.63 |
| Volume | 38,332 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (PRPO)
Nexqual's technical model rates PRPO "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:09 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 48.11 (neutral) |
| vs SMA50 | Below (USD 23.96) |
| MACD | -0.19 (negative) |
From PRPO's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RHEP | Regional Health Properties, Inc | USD 1.02 | ▲ 0.99% |
| CFOR | OpGen, Inc. | USD 7.78 | ▼ 61.1% |
| XBIO | Xenetic Biosciences, Inc. | USD 2.64 | ▼ 1.12% |
| VTVT | vTv Therapeutics Inc. | USD 30.73 | ▼ 2.97% |
| COCP | Cocrystal Pharma, Inc. | USD 0.9 | ▼ 4.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:09 UTC. This page is informational and not investment advice.